These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7885285)

  • 1. Effect of glucocorticoids on the paradoxical growth hormone response to thyrotropin-releasing hormone in patients with acromegaly.
    Giustina A; Doga M; Bresciani E; Bussi AR; Chiesa L; Misitano V; Giustina G
    Metabolism; 1995 Mar; 44(3):379-83. PubMed ID: 7885285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hydrocortisone on the growth hormone response to growth hormone-releasing hormone in acromegaly.
    Giustina A; Bussi AR; Doga M; Wehrenberg WB
    Horm Res; 1994; 41(1):33-7. PubMed ID: 8013941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of hydrocortisone on circulating growth hormone levels in patients with acromegaly.
    Giustina A; Bussi AR; Licini M; Pizzocolo G; Schettino M; Wehrenberg WB
    Horm Res; 1992; 37(6):212-6. PubMed ID: 1363409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly.
    Giustina A; Schettino M; Bossoni S; Bussi AR; Doga M; Licini M; Wehrenberg WB
    Metabolism; 1993 May; 42(5):664-8. PubMed ID: 8492725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute infusion of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in acromegalic patients.
    Díez JJ; Iglesias P; Sastre J; Gómez-Pan A
    Eur J Endocrinol; 2000 Aug; 143(2):203-11. PubMed ID: 10913939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexarelin, a novel GHRP-6 analog, counteracts the inhibitory effect of hydrocortisone on growth hormone secretion in acromegaly.
    Giustina A; Bresciani E; Bugari G; Bussi AR; Deghenghi R; Imbimbo B; Giustina G
    Endocr Res; 1995 Aug; 21(3):569-82. PubMed ID: 7588427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pyridostigmine on the hydrocortisone-mediated decrease of circulating growth hormone levels in acromegaly.
    Giustina A; Bussi AR; Doga M; Iacobello C; Wehrenberg WB
    Horm Metab Res; 1994 Jun; 26(6):288-92. PubMed ID: 7927192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
    Utsumi A; Hanew K; Sugawara A; Shimizu Y; Murakami O; Ikeda H; Yoshinaga K
    J Endocrinol Invest; 1992 Mar; 15(3):167-71. PubMed ID: 1624675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone increases serum levels of growth hormone-releasing hormone and growth hormone in patients with acromegaly.
    Hulting AL; Theodorsson E; Werner S
    J Intern Med; 1992 Sep; 232(3):229-35. PubMed ID: 1402619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in uremic patients.
    Díez JJ; Iglesias PL; Sastre J; Gómez-Pan A; Selgas R; Martínez-Ara J; Miguel JL; Méndez J
    Kidney Int; 1994 Nov; 46(5):1387-91. PubMed ID: 7853798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metoclopramide on the paradoxical growth hormone response to galanin in acromegaly.
    Giustina A; Doga M; Bodini C; Bossoni S; Bresciani E; Bussi AR
    Endocr Res; 1993 Dec; 19(4):303-15. PubMed ID: 7508379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.
    Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Colasanti S; Barini A
    Metabolism; 1992 Sep; 41(9):949-53. PubMed ID: 1355581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide.
    Watanobe H; Sasaki S; Sone K; Takebe K
    J Clin Endocrinol Metab; 1991 May; 72(5):982-5. PubMed ID: 1902488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
    Hanew K; Aida M; Sasaki A; Mouri T; Yoshinaga K
    Tohoku J Exp Med; 1979 Jan; 127(1):53-62. PubMed ID: 104407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
    Losa M; Alba-Roth J; Sobieszczyk S; Schopohl J; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):383-9. PubMed ID: 2494827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
    Hanew K; Aida M; Tano T; Yoshinaga K
    Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone response to thyrotropin-releasing hormone in acromegalic patients: reproducibility and dose-response study.
    Villabona CM; Soler J; Virgili N; Gómez JM; Montaña E; Navarro MA
    Horm Res; 1992; 37(1-2):14-17. PubMed ID: 1398470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
    Colao A; Merola B; Ferone D; Calabrese MR; Longobardi S; Spaziante R; Di Renzo G; Annunziato L; Lombardi G
    Eur J Endocrinol; 1994 Jul; 131(1):14-9. PubMed ID: 8038903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.